(4R,5S)-4-HYDROXY-5-METHYL-5-((4-(4-(4-(TRIFLUOROMETHOXY)PHENOXY)-1-PIPERIDINYL)PHENOXY)METHYL)-2-OXAZOLIDINONE
UNII B6YM2ZZ3LP
Substance Identification & Data
This profile provides standardized clinical and technical data for (4r,5s)-4-hydroxy-5-methyl-5-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-2-oxazolidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6YM2ZZ3LP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1202876-06-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H25F3N2O6 KLVSNMXKCKZXKU-IRLDBZIGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4r,5s)-4-hydroxy-5-methyl-5-((4-(4-(4-(trifluoromethoxy)phenoxy)-1-piperidinyl)phenoxy)methyl)-2-oxazolidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.